Eppendorf and BioLabs have officially announced the expansion of their long-standing strategic partnership to include the newly established BioLabs | TUM site in Munich. This latest move marks a significant deepening of a collaborative relationship that has already successfully spanned multiple key markets, including Germany, France, and the United States.
The Munich facility, which officially opened its doors in the summer of 2026, serves as a premier hub for life-science innovation. It offers a comprehensive suite of resources, including both shared and private laboratory spaces, administrative offices, and essential operational support. Beyond the physical infrastructure, the site provides tenants with invaluable access to a curated network of entrepreneurs, industry mentors, investors, and strategic partners, all aimed at accelerating the development of next-generation biotech ventures.
As part of this expansion, Eppendorf—a global leader in the development, manufacturing, and distribution of laboratory instruments and consumables—has stepped into the role of a BioLabs | TUM Gold Sponsor. Under this agreement, Eppendorf will provide specialized technologies and technical expertise designed to bolster the daily research operations and long-term growth of the startups housed within the Munich facility.
Axel Ziemke, Vice President of the Central Area EMEA for Eppendorf Vertrieb Deutschland GmbH, emphasized that the collaboration is specifically tailored to meet the needs of a new generation of biotech pioneers.
“This expansion serves a new generation of biotechs,” Ziemke stated. “It is particularly meaningful in terms of providing these innovators with immediate accessibility to Eppendorf’s high-quality equipment and deep technical expertise.”
Ziemke further noted that the partnership goes beyond simply providing hardware; it facilitates a “direct exchange” between Eppendorf’s technical teams and the innovative companies on-site, creating a feedback loop that encourages practical, hands-on advancement in laboratory workflows.
Johannes Fruehauf, CEO and Founder of BioLabs, reflected on the decade-long history between the two organizations, expressing pride in how the partnership has evolved.
“BioLabs’ partnership with Eppendorf spans more than a decade,” Fruehauf said. “We are very proud to extend this long-standing collaboration to Munich. Our mission is to support entrepreneurs and innovative scientists as they bring breakthrough ideas to life. We are confident that Eppendorf shares that commitment, and we are excited to have them join us in supporting the next generation of life-science companies in Munich.”
Looking ahead, both companies have indicated that this expansion is not the conclusion of their collaboration, but rather a foundation for future growth. Executives from both sides confirmed their intention to continue building upon the partnership, with a firm focus on strengthening the life sciences ecosystem throughout the Munich region. As the site continues to scale, the combined influence of Eppendorf and BioLabs is expected to play a pivotal role in shaping the commercial viability of emerging research in the area.
Disclaimer: This content is auto-generated for informational purposes only.
Source: Read Original News
